Article Information
vol. 6 no. 2
Published By
Online ISSN
History
- Received December 3, 2019
- Accepted February 18, 2020
- Published online April 19, 2020.
Copyright & Usage
Copyright ©ERS 2020 http://creativecommons.org/licenses/by-nc/4.0/This article is open access and distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0.
Author Information
- Katherine B. Hisert1⇑,
- Timothy P. Birkland1,
- Kelly Q. Schoenfelt2,
- Matthew E. Long1,
- Brenda Grogan3,
- Suzanne Carter3,
- W. Conrad Liles1,
- Edward F. McKone3,
- Lev Becker2,4 and
- Anne M. Manicone1,4
- 1Dept of Medicine, University of Washington, Seattle, WA, USA
- 2Ben May Dept for Cancer Research, University of Chicago, Chicago, IL, USA
- 3Dept of Medicine, St Vincent's University Hospital, Dublin, Ireland
- 4These authors contributed equally
- Katherine Hisert, National Jewish Health, 1400 Jackson St, Smith A550, Denver, CO 80206, USA. E-mail: hisertk{at}njhealth.org
Funding
Vertex Pharmaceuticals
Cystic Fibrosis Research Innovation Award, 200425/
Article usage
Altmetrics
Vol 6 Issue 2
Table of Contents
Ivacaftor decreases monocyte sensitivity to interferon-γ in people with cystic fibrosis
